Skip to Main

Search

Results 101 to 110 of 1,058 for ""

Exercise protects astronauts’ hearts during extended space missions : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/sept-exercise-protects-astronauts-hearts.html

Astronauts who spent up to six months aboard the International Space Station (ISS) experienced no loss of muscle mass or function in their ventricles – the pumping chambers of the heart – largely due to extensive exercise regimens, a new study led by UT Southwestern Medical Center researchers showed

AI accurately predicts cancer outcomes from tissue samples : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-ai-accurately-predicts-cancer-outcomes.html

Researchers at UT Southwestern Medical Center have developed a novel artificial intelligence (AI) model that analyzes the spatial arrangement of cells in tissue samples.

Treat yourself to healthy eating habits for the holidays: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/dec-healthy-eating-habits-for-the-holidays.html

Office parties and family dinners make eating healthy during the holiday season a challenge. But you can still enjoy your favorite treats while maintaining a balanced diet, according to nutrition experts at UT Southwestern Medical Center.

Blocking gene may halt growth of breast cancer cells: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/april-blocking-gene-breast-cancer-cells.html

Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center researchers showed in a new study.

Cancer cell–immune cell interactions predict immunotherapy response: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/april-cancer-cell-immune-cell-interactions.html

By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.

UTSW clinical trial sets stage for new paradigm in kidney cancer treatment: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-new-paradigm-in-kidney-cancer-treatment.html

Building upon previous work at UT Southwestern Medical Center, investigators report the results of a clinical trial exploring the role of stereotactic ablative radiation therapy (SAbR) for patients with a handful of metastases, or so-called oligometastatic disease.

Children’s Research Institute at UT Southwestern identifies metabolic inflexibility that keeps damage at bay during liver regeneration: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/july-childrens-ut-liver-regeneration.html

Liver cells have a vital metabolic inflexibility during regeneration to starve dysfunctional cells and keep damage from spreading, according to new research from Children’s Medical Center Research Institute at UT Southwestern (CRI) published in Science.

UTSW study sheds light on rare form of autism: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/may-light-on-rare-form-of-autism.html

A new study focused on the gene tied to a rare form of autism spectrum disorder (ASD) called FOXP1 syndrome offers hope that gene therapy might be able to help patients with this condition.

UT Southwestern researchers discover critical protein for common bone growth disorder: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/april-common-bone-growth-disorder.html

A team led by UT Southwestern Medical Center researchers has discovered a protein that appears to be pivotal for traumatic heterotopic ossification (HO), a condition in which bone forms in muscles, tendons, and other soft tissues after traumatic injury or surgery.

Warfarin use should not disqualify stroke patients from lifesaving clot-removing surgery: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/june-lifesaving-clot-removing-surgery.html

Most stroke patients taking the anticoagulant warfarin were no more likely than those not on the medication to experience a brain bleed when undergoing a procedure to remove a blood clot, UT Southwestern Medical Center researchers report in a new study.